<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Park HH</submitter><funding>National Research Foundation of Korea</funding><pagination>5631</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8463539</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(1)</volume><pubmed_abstract>Insulin/IGF-1 signaling (IIS) regulates various physiological aspects in numerous species. In Caenorhabditis elegans, mutations in the daf-2/insulin/IGF-1 receptor dramatically increase lifespan and immunity, but generally impair motility, growth, and reproduction. Whether these pleiotropic effects can be dissociated at a specific step in insulin/IGF-1 signaling pathway remains unknown. Through performing a mutagenesis screen, we identified a missense mutation daf-18(yh1) that alters a cysteine to tyrosine in DAF-18/PTEN phosphatase, which maintained the long lifespan and enhanced immunity, while improving the reduced motility in adult daf-2 mutants. We showed that the daf-18(yh1) mutation decreased the lipid phosphatase activity of DAF-18/PTEN, while retaining a partial protein tyrosine phosphatase activity. We found that daf-18(yh1) maintained the partial activity of DAF-16/FOXO but restricted the detrimental upregulation of SKN-1/NRF2, contributing to beneficial physiological traits in daf-2 mutants. Our work provides important insights into how one evolutionarily conserved component, PTEN, can coordinate animal health and longevity.</pubmed_abstract><journal>Nature communications</journal><pubmed_title>A PTEN variant uncouples longevity from impaired fitness in Caenorhabditis elegans with reduced insulin/IGF-1 signaling.</pubmed_title><pmcid>PMC8463539</pmcid><funding_grant_id>2019R1A3B2067745</funding_grant_id><funding_grant_id>2020R1C1C1013546</funding_grant_id><pubmed_authors>Ham S</pubmed_authors><pubmed_authors>Heo WD</pubmed_authors><pubmed_authors>Park HH</pubmed_authors><pubmed_authors>Kim E</pubmed_authors><pubmed_authors>Altintas O</pubmed_authors><pubmed_authors>Hwang W</pubmed_authors><pubmed_authors>Lee SV</pubmed_authors><pubmed_authors>Lee Y</pubmed_authors><pubmed_authors>Park S</pubmed_authors><pubmed_authors>Son HG</pubmed_authors><pubmed_authors>Lee D</pubmed_authors></additional><is_claimable>false</is_claimable><name>A PTEN variant uncouples longevity from impaired fitness in Caenorhabditis elegans with reduced insulin/IGF-1 signaling.</name><description>Insulin/IGF-1 signaling (IIS) regulates various physiological aspects in numerous species. In Caenorhabditis elegans, mutations in the daf-2/insulin/IGF-1 receptor dramatically increase lifespan and immunity, but generally impair motility, growth, and reproduction. Whether these pleiotropic effects can be dissociated at a specific step in insulin/IGF-1 signaling pathway remains unknown. Through performing a mutagenesis screen, we identified a missense mutation daf-18(yh1) that alters a cysteine to tyrosine in DAF-18/PTEN phosphatase, which maintained the long lifespan and enhanced immunity, while improving the reduced motility in adult daf-2 mutants. We showed that the daf-18(yh1) mutation decreased the lipid phosphatase activity of DAF-18/PTEN, while retaining a partial protein tyrosine phosphatase activity. We found that daf-18(yh1) maintained the partial activity of DAF-16/FOXO but restricted the detrimental upregulation of SKN-1/NRF2, contributing to beneficial physiological traits in daf-2 mutants. Our work provides important insights into how one evolutionarily conserved component, PTEN, can coordinate animal health and longevity.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-04T10:54:34.566Z</modification><creation>2025-04-04T10:54:34.566Z</creation></dates><accession>S-EPMC8463539</accession><cross_references><pubmed>34561453</pubmed><doi>10.1038/s41467-021-25920-w</doi></cross_references></HashMap>